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Abstract	
Bifurcation	aneurysms	account	for	a	large	fraction	of	cerebral	aneurysms	and	often	present	morphologies	that	render	traditional	endovascular	treatments,	such	as	coiling,	challenging	and	problematic.	Flow-diverter	stents	offer	a	potentially	elegant	treatment	option	for	such	aneurysms,	but	clinical	use	of	these	devices	remains	controversial.	Specifically,	the	deployment	of	a	flow-diverter	device	in	a	bifurcation	entails	jailing	one	or	more	potentially	vital	vessels	with	a	low-porosity	mesh	designed	to	restrict	flow.	When	multiple	device	placement	configurations	exist,	the	most	appropriate	clinical	decision	becomes	increasingly	opaque.	
		
In	this	study	three	bifurcation	aneurysm	geometries	were	virtually	treated	by	flow-diverter	device.	Each	aneurysm	was	selected	to	offer	two	possible	device	deployment	positions.	Flow-diverters	similar	to	commercially	available	designs	were	deployed	with	a	fast-deployment	algorithm	before	transient	and	steady	state	
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CFD	simulations	were	performed.	Reductions	in	aneurysm	inflow,	mean-	and	maximum-WSS,	all	factors	often	linked	with	aneurysm	treatment	outcome,	were	compared	for	different	device	configurations	in	each	aneurysm.	
	
In	each	of	the	three	aneurysms	modelled,	a	particular	preferential	device	placement	was	shown	to	offer	superior	performance	with	the	greatest	reduction	in	the	flow	metrics	considered.	In	all	three	aneurysm	geometries,	substantial	variations	in	inflow	reduction	(up	to	25.3%),	mean-WSS	reduction	(up	to	14.6%),	and	maximum-WSS	reduction	(up	to	12.1%)	were	seen,	which	were	all	attributed	to	device	placement	alone.	Optimal	device	placement	was	found	to	be	non-trivial	and	highly	aneurysm-specific;	in	only	one-third	of	the	simulated	geometries,	the	best	overall	performance	was	achieved	by	deploying	a	device	in	the	daughter	vessel	with	the	highest	flow	rate.	
	
Good	correspondence	was	seen	between	transient	results	and	steady	state	computations	that	offered	a	significant	reduction	in	simulation	run-time.	If	accurate	steady	state	computations	are	combined	with	the	fast-deployment	algorithm	used,	the	modest	run-time	and	corresponding	hardware	make	a	virtual	treatment	pipeline	in	the	clinical	setting	a	meaningful	possibility.	
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Introduction	
Flow-diverters	(FDs)	offer	a	unique	and	elegant	treatment	option	for	cerebral	aneurysms	at	risk	of	growth	or	rupture.	After	a	FD	device	has	been	deployed,	the	entire	cerebral	vessel	is	effectively	reconstructed	as	the	device	endothelialises	and	isolates	the	aneurysm	dome,	leading	to	thrombosis	and	eventual	aneurysm	shrinkage	and	reabsorption.(1)	Currently,	FDs	are	recommended	for	treatment	of	aneurysms	where	alternative	endovascular	(coiling)	or	surgical	(clipping)	treatments	are	unfeasible	or	have	previously	failed.(1)	However,	aneurysms	located	at	vessel	bifurcations,	which	account	for	the	majority	of	cerebral	aneurysms	by	some	estimates,(2)	are	also	thought	to	be	amenable	to	treatment	by	FD	device.(3,4)		
	
Bifurcation	aneurysms	present	a	potentially	significant,	and	entirely	irreversible,	clinical	choice	when	treatment	by	flow-diverter	has	been	elected:	in	which	daughter	vessel	should	the	device	be	placed	and	therefore	which	daughter	vessel(s)	should	be	jailed	with	the	device?	Such	a	decision	is	far	from	trivial,	and	a	number	of	competing	factors	must	be	weighed.	For	instance,	the	haemodynamic	environment	in	and	around	both	treated	and	untreated	bifurcation	aneurysms	is	often	highly	complex(5,6);	small	differences	in	daughter	vessel	diameter	and	angle	
5	
may	alter	the	effective	length	and	porosity	of	the	deployed	FD(7,8);	reduced	flow	to	jailed	daughter	vessels	may	result	in	loss	of	vessel	patency(9,10);	and	collateral	flow	to	jailed	daughter	vessels	may	prevent	aneurysm	occlusion.(11)	As	such,	bifurcation	aneurysm	treatment	by	FD	remains	rare	and	controversial.(12–15)	
	
Modelling	of	aneurysm	treatment,	and	specifically	thrombus	genesis	and	growth,	is	a	highly	complex	process.(16–18)	Although	animal	models	go	someway	towards	capturing	the	complex	biochemistry	involved,	the	aneurysms	created	in	these	models	are	often	rudimentary	in	their	morphology	and	offer	little	value	for	patient-specific	treatment	planning.(11,19,20)	Consequently,	a	number	of	surrogate	measures	extracted	from	patient-specific	CFD	models	are	often	correlated	with	likelihood	of	thrombus	growth.	Reduction	in	aneurysm	inflow	is	linked	to	increased	blood	residence	time	in	the	aneurysm	dome	and	corresponding	platelet	and	fibrin	aggregation.(21,22)	The	role	of	wall	shear	stress	(WSS)	in	aneurysm	treatment	is	more	complex	with	extremes	of	both	high-	and	low-WSS	linked	to	negative	outcomes.(2,5,23,24)	However,	a	number	of	bio-chemical	models	correlate	an	overall	reduction	in	WSS	with	platelet	deposition	and	thrombosis	growth.(25,26)	But,	such	heuristics	should	be	viewed	cautiously	with	studies	in	the	literature	also	suggesting	that	both	spatial	and	temporal	variations	
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in	WSS	distribution,	including	local	jetting	and	harmonic	frequencies,	may	also	play	a	significant	role	in	thrombus	initiation	and	growth.(27–29)	
	
In	this	study,	three	Basilar	artery	bifurcation	aneurysms	are	examined	with	CFD	models,	and	the	effects	of	different	FD	configurations	on	aneurysm	inflow	reduction	and	changes	in	mean	and	peak	WSS	are	evaluated.	Each	aneurysm	geometry	was	chosen	to	have	relatively	symmetric-sized	daughter	vessels	(Posterior	Cerebral	Arteries),	thus	rendering	the	treatment	decision	of	where	to	deploy	a	FD	device	non-obvious.	
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Methodology	
Three	bifurcation	aneurysm	geometries	located	at	the	Basilar	tip	were	selected	and	segmented	from	MRA	data	in	OsiriX	(OsiriX	v.4.1.1,	Freeware)	and	converted	to	STL	format.	The	geometries	were	imported	into	Blender	(Stichting	Blender	Foundation,	Amsterdam,	The	Netherlands)	and	were	trimmed	to	result	in	vessel	lengths	of	around	five	vessel	diameters	distal	and	proximal	to	the	aneurysm	location,	as	shown	in	Figure	1.	
	
	
Figure	1:	Bifurcation	aneurysm	geometries	I,	II,	and	III	located	at	the	Basilar	tip,	with	
side	views	inset.	(B:	Basilar	Artery,	(L)P:	(Left)	Posterior	Cerebral	Artery,	(L)S:	(Left)	
Superior	Cerebellar	Artery)	
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A	generic	flow-diverter	device	(shown	in	Figure	2)	was	created	with	70%	porosity	and	both	a	mesh	design	and	wire	diameter	similar	to	the	two	devices	commonly	used	clinically:	the	Silk	Flow	Diverter	(SILK;	Balt	Extrusion,	Montmorency,	France)	and	the	Pipeline	Embolization	Device	(PED;	Covidien/Medtronic,	Minneapolis,	MN,	USA).	
	
Device	Deployment	
Device	deployment	was	completed	with	an	in-house	fast-deployment	algorithm	based	on	a	spring	analogy	and	implemented	in	Matlab	(Mathworks,	Natick,	MA,	USA)	and	Blender,	the	details	of	which	have	been	previously	reported	by	the	authors(25,30)	and	are	not	given	here	for	the	sake	of	brevity.	Briefly,	the	device	is	first	converted	to	a	centreline	representation,	compressed	radially,	and	aligned	with	the	vessel	to	mimic	the	device	sheathed	by	a	catheter.	The	radial	compression	of	the	device	is	then	relaxed	progressively	along	its	length	in	an	action	similar	to	unsheathing.	The	device	attempts	to	expand	to	its	stress-free	diameter	and	is	opposed	by	the	vessel	wall.	An	offset	in	the	device	contact	condition	then	allows	for	thickness	to	be	added	back	to	the	deployed	centreline	configuration,	yielding	the	3D	device	in	its	deployed	position.	The	deployed	device	is	finally	trimmed	by	
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removing	the	lengths	in	the	parent	and	daughter	vessels	(as	shown	in	Figure	2),	in	order	to	reduce	the	size	of	subsequently	generated	CFD	meshes,	and	to	improve	overall	computational	efficiency.	
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Figure	2:	Deployed	device	positions	in	each	aneurysm	geometry	(I-III)	and	each	
device	configuration	(Left	or	Right).	Devices	are	shown	trimmed	prior	to	mesh	
generation	
	
A	flow-diverter	device	was	deployed	in	each	aneurysm	geometry	in	two	different	positions,	as	shown	in	Figure	2,	corresponding	to	each	PCA.	Device	equilibrium	was	achieved	in	less	than	200	iterations	of	the	deployment	algorithm	and	in	near	real-time.	Device	sizing	was	chosen	following	the	SILK	and	PED	manufacturers’	guidance.		
	
Meshing	and	Solver	Setup	
The	aneurysm	geometries	with	and	without	devices	deployed	were	meshed	using	CFD-VisCART	(ESI	Group,	Paris,	France)	using	a	Projected	Single	Domain	conforming	unstructured	mesh,	an	Omnitree	Cartesian	tree	type,	and	three	near-wall	Cartesian	layers	to	give	a	smooth	and	well-resolved	boundary	definition.	The	meshes	were	then	imported	into	the	multi	physics	suite	CFD-ACE+	(ESI	Group,	Paris,	France).	
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Blood	was	modelled	as	an	incompressible	fluid	with	unsteady	3D	Navier–Stokes	governing	equations	that	were	solved	following	the	finite	volume	approach,	with	a	Central	Differencing	scheme	for	spatial	differentiations	and	interpolations,	as	well	as	a	Crank–Nicholson	second-order	scheme	for	time-marching.	The	SIMPLE-Consistent	(SIMPLEC)	pressure	correction	method(31,32)	and	an	algebraic	multigrid	method	for	convergence	acceleration(33)	were	used.	Given	previous	studies	in	the	literature	that	confirmed	the	non-Newtonian	effects	of	blood	to	be	small	in	the	cerebral	circulation,(34,35)	blood	is	modelled	as	a	Newtonian	fluid	with	a	density	of	1000	kg/m3	and	a	dynamic	viscosity	of	0.004	Pa	s.	Arterial	walls	were	modelled	as	rigid,	with	the	effect	of	such	an	assumption	on	flow	patterns	having	been	shown	to	be	negligible.(36)	A	no-slip	boundary	condition	was	imposed	on	both	the	vessel	walls	and	device	struts.	
	
Both	steady	state	and	transient	computations	were	performed	assuming	a	mean	flow	rate	of	120ml/min,	a	cardiac	profile	based	on	that	reported	by	Valencia	et	al.,(35)	and	a	heart	rate	of	75	BPM.	In	both	cases,	Poiseuille	flow	was	assumed,	and	a	parabolic,	radially	symmetric	velocity	profile	was	prescribed	at	each	geometry	inlet	along	with	a	constant	pressure	boundary	condition	at	all	outlets.	A	constant	time-step	of	0.001	seconds	was	used	across	all	transient	computations	with	three	
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cardiac-cycles	simulated.	Results	were	obtained	from	the	third	cycle	only,	to	reduce	the	effects	of	initial	transients.	
	
Inlet	Reynolds	numbers	in	the	range	of	221-270	were	seen	across	the	steady	state	simulations.	For	the	transient	simulations,	mean	inlet	Reynolds	numbers	in	the	range	of	221-270	were	observed	with	an	instantaneous	value	of	192-405.	The	relatively	small	inlet	Womersley	numbers	(1.68-1.89)	confirmed	little	departure	in	transient	velocity	profile	from	the	parabolic	steady	state	case.	
	
Post-Processing	
A	plane	was	placed	at	the	aneurysm	neck	in	each	geometry	through	which	aneurysm	inflow	was	measured.	This	plane	also	served	to	separate	the	aneurysm	dome	from	the	parent	vasculature	with	aneurysm	WSS	then	calculated	on	the	aneurysm	surface	distal	of	the	inlet	plane.	Transient	simulation	results	were	reported	as	both	the	mean,	calculated	by	averaging	distributions	taken	at	0.02	seconds	intervals,	and	the	range	over	the	cardiac	cycle.		
		
Mesh	Independence	
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The	CFD	simulations	in	this	study	are	particularly	sensitive	to	mesh	refinement,	as	the	deployed	flow-diverter	device	has	a	very	fine	construction	(~35μm	wire	diameter	and	~200μm	typical	pore	size)	over	which	large	velocity	gradients	are	present.	As	such,	a	comprehensive	mesh	independence	study	was	performed	to	evaluate	any	mesh-induced	discretisation	error	in	the	key	metrics	used	to	evaluate	device	performance.	
	
	
Figure	3:	Aneurysm	inflow	reduction	mesh	independence	showing	<1%	variation	in	
inflow	at	a	minimum	mesh	density	greater	than	approximately	4,000	cells/mm3	
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Meshes	of	all	three	aneurysm	geometries	with	and	without	devices	deployed	were	created	with	approximate	minimum	mesh	densities	in	the	range	of	50-50,000	cells/mm3,	which	resulted	in	mesh	sizes	of	0.088-28.0	million	cells.	Steady	state	computations	at	mean	flow	rate	were	performed	for	each	mesh	density	across	all	three	geometries	using	the	same	solver	parameters	previously	detailed.	The	relative	reduction	in	aneurysm	inflow	(Qin),	mean	aneurysm	WSS	(WSSmean),	and	maximum	aneurysm	WSS	(WSSmax)	for	each	mesh	density	in	each	aneurysm	and	device	combination	are	detailed	in	Figures	3,	4	and	5	respectively.		
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Figure	4:	Aneurysm	mean	WSS	reduction	mesh	independence	showing	<2%	variation	
in	inflow	at	a	minimum	mesh	density	greater	than	approximately	4,000	cells/mm3	
	
From	the	figures,	it	can	be	assumed	that	simulations	conducted	with	a	minimum	mesh	density	around	4,000	cells/mm3	result	in	less	than	1%	variation	in	Qin	and	WSSmax	and	less	than	2%	variation	in	WSSmean,	due	to	mesh	discretisation	effects	alone.		Mesh	refinement	to	this	level	produced	meshes	of	between	2.88	and	14.7	million	cells	for	the	aneurysm	geometries	with	and	without	a	device	deployed.		Details	of	the	mesh	cell	size	and	refinement	near	the	device	struts	are	shown	in	
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Figure	6	for	the	level	of	mesh	independence	discussed.	This	level	of	mesh	refinement	is	consistent	with	previous	mesh	independence	studies	conducted	by	the	authors	for	both	steady	state	and	transient	computations.(25)		
	
	
Figure	5:	Aneurysm	maximum	WSS	reduction	mesh	independence	showing	<1%	
variation	in	inflow	at	a	minimum	mesh	density	greater	than	approximately	4,000	
cells/mm3	
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Solution	time-step	independence	for	the	transient	computations	was	also	assumed	at	a	time-step	of	0.001	seconds,	as	previously	detailed.	No	appreciable	difference	was	observed	in	the	metrics	discussed	above	for	solutions	conducted	at	time-steps	of	0.01-0.001	seconds,	in	line	with	similar	studies	by	the	authors	reported	elsewhere.(25)	In	this	particular	study	the	greatest	computational	efficiency	was	achieved	with	the	0.001-second	time-step.		
	
	
Figure	6:	Detail	of	mesh	cell	size	and	refinement	at	flow-diverter	device	struts	for	the	
“mesh	independent”	mesh	discussed	
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Results	and	Discussion	
The	corresponding	reductions	in	aneurysm	inflow	(Qin),	mean	WSS	(WSSmean)	and	maximum	WSS	(WSSmax)	for	each	geometry	and	device	combination	are	plotted	in	Figures	7,	8	and	9	respectively.	Across	all	three	metrics	plotted	in	the	figures	it	is	apparent	that	the	steady	state	solution	(indicated	in	red)	offers	a	good	approximation	to	the	mean	transient	distribution	(in	blue),	despite	around	a	50-fold	reduction	in	computational	load.	
	
Transient	variation	in	the	reduction	of	both	aneurysm	inflow	and	WSS	(indicated	in	black	for	Figures	7,	8	and	9)	is	relatively	similar	across	all	aneurysm	and	device	combinations.	In	all	cases,	the	lowest	reduction	is	seen	at	maximum	parent	vessel	flow	rate	(peak	systole)	and	the	greatest	reduction	is	seen	at	minimum	parent	vessel	flow	rate.	These	two	conditions	correspond	to	approximately	150%	and	87%	of	mean	parent	vessel	flow	rate	respectively,	with	a	similar	degree	of	asymmetry	then	seen	in	the	corresponding	variation	about	the	mean	percentage	reduction	in	each	case.		
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Figure	7:	Aneurysm	inflow	reduction	by	geometry	and	device	position.	Steady	state	
results	are	indicated	in	red,	with	the	mean	and	range	of	transient	results	indicated	in	
blue	and	black	respectively	
	
In	Figure	7	substantial	differences	in	inflow	reduction,	dependent	on	device	position	alone,	are	seen	in	two	aneurysms:	a	difference	of	25.3%	for	Aneurysm	I	and	5.5%	for	Aneurysm	II.	No	significant	difference	(<1%)	in	inflow	reduction	is	seen	in	Aneurysm	III.	It	is	particularly	striking	that	with	a	device	deployed	in	the	
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left	and	right	daughter	vessels	respectively,	Aneurysm	I	offers	both	the	highest	and	lowest	inflow	reductions	seen	across	all	the	simulation	results.	
	
	
Figure	8:	Aneurysm	mean	WSS	reduction	by	geometry	and	device	position.	Steady	
state	results	are	indicated	in	red,	with	the	mean	and	range	of	transient	results	
indicated	in	blue	and	black	respectively	
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Although	less	variation	is	seen	in	mean-WSS	reduction	across	the	aneurysm	and	device	combinations	(shown	in	Figure	8),	the	differences	of	14.6%	and	6.5%,	for	Aneurysms	I	and	III	respectively	are	still	notable.	
	
The	corresponding	differences	in	maximum-WSS	reduction	(Figure	9)	are	more	modest	still,	at	5.7%,	3.3%	and	12.1%	for	Aneurysms	I,	II	and	III	respectively,	but	an	emerging	pattern	of	a	more	successful	device	placement	position	in	each	aneurysm	is	further	reinforced.		
	
Overall	the	percentage	reduction	in	both	measures	of	WSS	is	consistently	higher	(>75%	in	all	cases)	than	the	reduction	in	aneurysm	inflow	achieved,	which	ranges	from	approximately	45%	to	70%.	Across	all	three	aneurysms,	one	configuration	of	device	placement	appears	to	offer	better	performance	in	each	case:	the	left	configuration	for	Aneurysm	I,	and	the	right	configuration	for	Aneurysms	II	and	III.	In	each	case	(excluding	Aneurysm	III	Qin	and	Aneurysm	II	WSSmean),	this	preferential	configuration	significantly	reduces	each	metric	examined.	As	such,	these	preferential	device	positions	may	then	translate	to	an	increased	probability	of	aneurysm	thrombosis	and	successful	treatment	outcome,	although	such	an	assertion	is	currently	unverified.	
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Figure	9:	Aneurysm	maximum	WSS	reduction	by	geometry	and	device	position.	
Steady	state	results	are	indicated	in	red,	with	the	mean	and	range	of	transient	results	
indicated	in	blue	and	black	respectively	
	
Across	all	three	aneurysm	geometries,	both	with	and	without	a	device	deployed,	one	of	the	two	daughter	vessels	considered	is	dominant	and	transports	a	larger	overall	fraction	of	the	parent	vessel	flow	rate,	as	shown	in	Table	1.	The	variation	due	to	device	positioning	in	the	proportion	of	flow	exiting	each	daughter	vessel	is	
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very	small	(<2%	of	the	total	flow	rate	in	all	cases).	Interestingly,	the	preferential	device	configuration	for	both	Aneurysms	I	and	III	corresponds	to	deploying	the	flow-diverter	device	in	the	non-dominant	daughter	vessel	with	a	lower	overall	fraction	of	outflow.		
	
Table	1:	Percentages	of	total	mean	flow	exiting	each	daughter	vessel	with	No	Device	
deployed	and	by	deployed	device	configuration	(Left	and	Right).	The	relative	increase	
or	decrease	in	vessel	flow	rate	from	the	No	Device	case	is	also	indicated	in	brackets.	
		
Figures	10	and	11	detail	the	streamlines	and	wall	shear	stress	distributions	for	each	aneurysm	and	begin	to	illustrate	some	underlying	mechanisms	behind	the	variation	due	to	device	positioning	seen	in	Figures	7,	8	and	9.		The	details	of	these	distributions	are	discussed	on	a	case-by-case	basis	below:	
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Aneurysm	I	
The	large	variation	in	aneurysm	inflow	reduction	for	the	Aneurysm	I	geometry,	seen	in	Figure	7,	is	also	clearly	visible	in	the	streamlines	of	Figure	10.	For	Aneurysm	I	with	a	device	deployed	in	either	daughter	vessel,	blood	enters	on	the	right-hand	side	of	the	aneurysm	but	then	exits	in	the	direction	corresponding	to	the	un-stented	daughter	vessel.	Consequently,	flow	is	both	entering	and	exiting	the	aneurysm	in	the	same	region	in	the	Left	configuration,	which	appears	to	substantially	reduce	the	degree	to	which	higher	speed	(~0.25	ms-1)	flow	penetrates	the	aneurysm	dome.	By	contrast,	in	the	Right	device	configuration	almost	all	flow	enters	the	aneurysm	dome	on	the	right,	circulates	throughout	the	entire	aneurysm	dome	and	then	exits	through	the	un-stented	left	daughter	vessel.	
	
The	variation	in	Qin	reduction	seen	between	device	configurations	for	Aneurysm	I	may	be	due	to	difference	in	apparent	porosity	of	the	device,	which	is	dependent	upon	both	the	degree	of	device	opening	and	the	incident	angle	at	which	flow	strikes	the	device	mesh.	In	the	Left	configuration,	flow	at	the	aneurysm	neck	appears	to	strike	the	device	at	a	shallower	angle	than	for	the	Right,	thereby	increasing	the	device’s	relative	porosity.	Similarly,	in	the	Right	case,	the	wider	
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ostium	of	the	right-hand	daughter	vessel	may	result	in	greater	device	opening	and	lower	device	porosity	locally,	precisely	where	significant	aneurysm	inflow	occurs.		
	
However,	the	inflow	reduction	seen	for	Aneurysm	I	does	not	appear	to	be	explained	by	porosity	alone.	The	proportion	of	overall	flow	in	each	stented	daughter	vessel,	34.8%	and	41.2%	respectively	for	the	Left	and	Right	cases,	implies	that	more	flow	passes	through	the	device	mesh	in	the	Left	case:	65.3%	vs	58.8%.	But,	a	lower	proportion	of	the	flow	passing	through	the	device	then	enters	aneurysm	dome	in	the	Left	case,	a	phenomenon	that	appears	to	be	dictated	by	the	aneurysm	geometry	and	overall	flow	environment.	Overall,	Aneurysm	I	has	the	least	symmetric	aneurysm	dome	and,	correspondingly,	the	least-symmetric	aneurysm	flow	pattern.	Although	not	included	in	the	figure,	a	similar	flow	pattern	to	the	Right	configuration	was	observed	when	no	device	was	deployed	in	the	aneurysm	geometry.		
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Figure	10:	Flow	streamlines	for	transient	simulations	shown	at	mean	flow	rate	by	
geometry	and	device	position.	Inflow	(red)	and	outflow	(blue)	regions	of	the	
aneurysm	inlet	plane	are	also	shown	
	
The	WSS	distributions	in	Aneurysm	I	follow	a	similar	pattern	to	the	flow	streamlines	for	the	corresponding	device	positions.	For	mean-WSS	value,	the	Left	
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and	Right	device	configurations	again	represent	the	highest	and	lowest	reductions	respectively	seen	across	all	aneurysms.	As	shown	in	Figure	11,	there	are	significant	spatial	differences	in	the	aneurysm	WSS	distributions	for	the	Left	and	Right	configurations.	This	difference	is	most	stark	on	the	front	face	of	the	aneurysm	dome	(left-hand	image	of	each	pair),	where	in	the	Left	configuration	local	flow	stasis	has	reduced	the	WSS	to	very	near	zero	across	the	entire	surface.	Overall,	in	both	deployment	positions,	the	device	reduces	the	entire	aneurysm	WSS	distribution	to	a	magnitude	considered	physiologically	normal.	
	
Aneurysm	II	
The	inflow	patterns	of	Aneurysm	II	are	very	similar	across	the	Left	and	Right	configurations,	as	shown	in	Figure	10.	In	both	cases	higher-velocity	flow	enters	in	the	neck	region	towards	the	back-face	of	the	aneurysm,	and	this	flow	then	circulates	through	the	entire	aneurysm	dome	as	a	single	vortex	before	exiting	along	the	front	edge	of	the	aneurysm	neck.	In	each	case	the	majority	of	the	blood	leaving	the	aneurysm	appears	to	do	so	in	the	direction	of	the	corresponding	un-stented	daughter	vessel.		
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The	angle	at	which	flow	strikes	the	device	mesh	and	the	daughter	vessel	ostium,	and	hence	the	effective	device	porosity,	appear	similar	for	both	device	configurations.	Thus,	the	relatively	small	5.5%	difference	in	Qin	reduction	seen	between	the	Left	and	Right	configurations	may	not	be	the	result	of	porosity	differences,	but	the	different	fractions	of	flow	exiting	via	each	daughter	vessel	alone.	As	shown	in	Table	1,	a	larger	fraction	of	the	overall	flow	passes	through	the	device	mesh	in	the	Left	compared	to	the	Right	configurations	(69.1%	vs	55.2%).	Hence,	given	the	very	similar	overall	flow	regimes	between	the	two	configurations,	it	seems	logical	more	flow	would	then	enter	the	aneurysm	overall	in	the	Left	configuration	and	thereby	reduce	the	device’s	Qin	reduction.	
	
The	WSS	distributions	for	each	deployed	device	position	also	appear	almost	identical,	which	correlates	with	the	insignificant	different	in	mean	WSS	reduction	detailed	in	Figure	8.	Although	slightly	elevated	areas	of	WSS	are	common	to	both	device	configurations,	in	each	case	the	elevated	areas	are	shifted	marginally	away	from	the	stented	daughter	vessel,	especially	at	the	aneurysm	neck.	These	areas	of	higher	WSS	occur	in	regions	where	flow	exits	the	aneurysm	dome	via	the	un-stented	daughter	vessel.	In	both	the	Left	and	Right	device	configurations,	peak	WSS	values	are	located	in	these	regions	and	adjacent	to	the	un-stented	daughter	vessel	
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in	each	case.	As	in	the	case	of	Aneurysm	I,	both	device	positions	reduce	the	WSS	in	the	entirety	of	the	aneurysm	dome	to	values	considered	physiologically	normal.		
	
	
Figure	11:	WSS	distributions	for	transient	simulations	shown	at	mean	flow	rate	by	
geometry	and	device	position	(front	and	back	views)	
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Aneurysm	III	
For	Aneurysm	III	the	inflow	streamlines	are	also	similar	regardless	of	device	positioning,	as	shown	in	Figure	10.	Broadly,	flow	enters	the	aneurysm	in	the	front-central	portion	of	the	neck	and	circulates	towards	the	back	face	in	two	vortices	that	are	aligned	with	the	lobes	of	the	aneurysm	dome.	A	very	similar	flow	pattern	was	also	seen	in	the	No	Device	case,	which	is	not	included	in	the	figure	for	brevity.		
	
Again,	flow	appears	to	exit	the	aneurysm	primarily	in	the	direction	of	the	un-stented	vessel.	Although	more	of	the	total	flow	passes	through	the	device	mesh	in	the	Right	configuration	(65.1%	vs.	52.1%)	a	significant	fraction	of	the	flow	moves	directly	into	the	un-stented	(left)	daughter	vessel	in	this	case.	By	contrast,	the	flow	enters	the	un-stented	(right)	daughter	vessel	in	the	Left	configuration	almost	entirely	via	the	aneurysm	dome.	Hence,	as	in	the	case	of	Aneurysm	I,	although	more	flow	passes	through	the	device	mesh	in	the	preferential	configuration,	the	local	flow	environment	results	in	a	smaller	fraction	of	this	flow	entering	the	aneurysm	dome.	
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Despite	a	very	similar	inflow	reduction	between	the	Left	and	Right	configurations,	the	flow	entering	the	Left	geometry	does	so	with	a	more	pronounced	jet,	which	penetrates	further	into	the	aneurysm	geometry	(see	Figure	10).	This	more	coherent	jet	structure	results	in	locally	increased	WSS	due	to	impact	at	the	tip	of	the	aneurysm	in	the	Left	configuration,	clearly	visible	in	Figure	11.	The	more	favourable	reductions	in	both	mean	and	maximum	WSS	achieved	by	the	device	deployed	in	the	Right	configuration	appear	to	be	a	direct	result	of	more	effective	suppression	of	this	inflow	jet.	For	Aneurysm	III,	as	in	all	other	cases,	the	deployment	of	a	flow-diverter	in	either	daughter	vessel	reduces	the	WSS	distribution	in	the	aneurysm	dome	to	a	range	considered	physiologically	normal.	
	
Across	all	three	aneurysm	geometries	an	increase	in	total	flow	delivered	to	both	daughter	vessels	considered	(Left	and	Right)	occurs	following	device	deployment	in	either	configuration	in	all	but	one	case:	Aneurysm	II	Left.	It	appears	in	the	remaining	five	cases	flow	to	the	other	two	daughter	vessels	(LS	and	RS	in	Figure	1	and	referred	to	collectively	as	“Others”	in	Table	1)	is	reduced	by	5.08-14.6%.	These	“Others”	vessels	are	jailed	in	all	device	configurations	and	are	both	smaller	in	diameter	than	the	Left	and	Right	vessels,	and	are	orientated	at	a	more	obtuse	angle	to	the	flow	direction	–	factors	that	appear	to	exacerbate	the	effects	of	jailing.	By	
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contrast,	there	does	not	appear	to	be	a	correlation	between	placement	of	a	device	in	a	vessel	and	a	corresponding	increase	in	vessel	flow	rate	for	the	Left	and	Right	vessels.	
	
Finally,	a	summary	of	the	simulation	workflow	completed	is	detailed	in	Table	2,	with	estimates	of	the	corresponding	execution	time	for	each	stage	of	the	virtual	treatment	pipeline.	A	complete	virtual	treatment	case	(with	and	without	a	device	deployed)	may	be	simulated	in	less	than	5	hours,	with	a	steady	state	calculation	and	an	assumption	of	a	solution	mesh	independence	to	the	level	discussed.	Comparing	two	devices	or	two	positions	of	the	same	device	would	require	around	a	further	2.5	hours.		
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Table	2:	Simulation	workflow	with	hardware	and	software	setups	and	corresponding	
execution	times.	1Assuming	a	mesh	size	equivalent	to	the	level	of	mesh-independence	
previously	detailed	
		
The	surprising,	and	perhaps	counter-intuitive,	flow	patterns	induced	by	different	device	positions	that	have	been	elucidated	in	this	study	illustrate	that	optimal	flow-diverter	placement	is	far	from	trivial.	With	the	computational	framework	proposed,	accurate	patient-specific	simulations	of	multiple	treatment	options	would	be	feasible	in	the	clinical	setting	with	overnight	computations	on	high-performance	desktop	hardware.	
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Study	Limitations	
The	results	of	this	computational	study	should	be	viewed	in	the	context	of	a	number	of	limitations.	The	small	quantity	of	aneurysm	geometries	simulated	immediately	limits	the	generalisability	of	the	study	conclusions,	and	it	is	unclear	whether	the	findings	presented	are	in	any	way	representative.	The	use	of	average	flow	profiles	and	flow	rates	in	addition	to	uniform	boundary	conditions	at	all	outlets	may	be	unrealistic	and	certainly	reduces	the	patient-specific	nature	of	the	simulations.	In	particular,	the	assumption	of	symmetric	outlet	boundary	conditions	may	be	unrealistic,	given	the	subtle	asymmetric	flow	patterns	observed	across	all	simulated	aneurysm	geometries.	Finally,	as	discussed	in	the	introduction,	the	flow	metrics	reported	in	this	study	are	considered	surrogate	measures	that	are	linked	with	aneurysm	thrombosis.	However,	the	precise	factors	governing	aneurysm	treatment	outcome	remain	poorly	understood,	rendering	any	predictions	of	significant	difference	in	treatment	outcome	due	to	device	position	entirely	unverified.	
	
Conclusions	
In	this	study	of	virtual	aneurysm	treatment,	substantial	differences	due	to	flow-diverter	device	position	alone	were	observed	for	a	number	of	haemodynamic	
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metrics	often	linked	with	positive	clinical	outcomes.	In	all	cases,	the	flow	environment	in	and	around	the	aneurysm	was	shown	to	be	complex	and	non-trivial.	In	two-thirds	of	the	aneurysms	the	greatest	reduction	in	the	metrics	was	achieved	when	a	flow-diverter	device	was	deployed	in	the	non-dominant	daughter	vessel	with	a	lower	overall	flow	rate.	Relatively	subtle	differences	in	overall	aneurysm	morphology,	and	particularly	the	degree	of	aneurysm	symmetry,	were	shown	to	result	in	substantial	changes	in	haemodynamic	environment	following	device	deployment.	Although	device	jailing	appears	to	reduce	the	flow	rate	in	smaller	daughter	vessels	that	were	angled	away	from	the	flow	direction,	flow	in	larger	vessels	appeared	relatively	unaffected	by	the	device.	
	
A	larger	study	of	the	same	virtual	treatment	procedure	has	the	potential	to	elucidate	haemodynamic	mechanisms	underlying	the	high	failure-rate	of	bifurcation	aneurysms	treated	by	flow-diverter	that	are	detailed	in	the	literature.	For	the	aneurysms	discussed,	combining	steady	state	CFD	simulations	with	simplified	device	deployment	techniques	results	in	a	computational	load	sufficiently	modest	enough	to	make	such	predictions	a	possibility	in	the	clinical	setting.	
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